Several studies have demonstrated that PD-L2 is associated with patient outcomes in different cancers (38).Neutralization of PD-L2 has been shown to be crucial for overcoming immune checkpoint resistance in OvCa (39). Here, PDCD1LG2 is linked to cancer.